NOI - Sole Source Notice of Intent_2261604_FINAL.pdf

SAM.gov Synopsis

Document Type: Synopsis

Solicitation Number: NOI-NIAID-25-2261604

Posted Date: 08/13/2025

Response Date: 08/18/2025

Set Aside: None

NAICS: 541380 – Testing Laboratories and Services

Contracting Office Address:

Department of Health and Human Services, National Institutes of Health, National Institute of

Allergy & Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852

Title: Clinical Long Read Genomics services for the NIAID Centralized Sequencing Program

Primary Point of Contact: Secondary Point of Contact

Tasha Lee – tasha.lee@nih.gov Linda Smith – linda.smith2@nih.gov

Description:

THIS IS A NOTICE OF INTENT AND NOT A REQUEST FOR QUOTATIONS

This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a

Notice of Intent to award a sole source, firm-fixed price order under the authority of 41 U.S.C.

3304(a)(1), as implemented by FAR 6.302-1 - Only One Responsible Source and No Other

Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive proposals.

The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate on a sole source basis with Children’s Mercy Kansas City, 2401 Gillham Road, Kansas City, MO

64108.

The National Institute of Allergy and Infectious Disease (NIAID) Division of Intramural

Research (DIR) scientists study all aspects of infectious diseases, including the causative agent, vectors, and pathogenesis in human and animal hosts. Clinical research is an integral part of this mission, enabling key lab discoveries to be rapidly translated into methods to prevent, diagnose, or treat disease. DIR researchers annually conduct more than 200 clinical trials at the NIH Clinical Center on the Bethesda, Maryland, campus and at collaborating U.S.

and international sites.

In support of clinical research, the NIAID Centralized Sequencing Program (CSP) is comprehensive program that obtains genetic testing, harmonizes phenotypic and genomic data, performs variant interpretation, and provides clinically validated results for patients enrolled in protocols at the NIH Clinical Center. The goal of the NIAID Centralized

Sequencing Program is both to contribute to the understanding of underlying genetic etiology of disease and to address the clinical need for genomic evaluations.

The purpose of this acquisition is to support the mission of DIR to obtain genetic testing for the NIAID CSP. The objective is to purchase both symptom-driven long read sequencing analysis and targeted long read sequencing. The results of this testing will have direct implications for the care of NIH patients and for the discovery of disease mechanisms.

The scope of this effort includes the services and industry knowledge necessary to provide long read sequencing as specified in this SOW.

Period of Performance: One 12-month period

Place of Performance: Bethesda, MD.

The North American Industry Classification (NAICS) for this acquisition is 541380

This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 15 days of this notice.

While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that

Children’s Mercy Kansas City is the only vendor who can provide the requested services for

NIAID. However, firms that believe they can provide the capability required to fully meet the

Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact within 10 days after publication of this notice.

Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the

Government. Interested parties may identify their interest and capability to respond to the requirement or submit offers on NOI-NIAID-25-2261604.

This notice does not obligate the Government to award a contract or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

For additional information or to submit responses, please contact Tasha Lee, Contracting

Specialist at tasha.lee@nih.gov mailto:tasha.lee@nih.gov